Clinical Trial Update: Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the tolerability, pharmacokinetics, and pharmacodynamics of INS50589 given by intravenous infusion in healthy volunteers, with cardiova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• INS50589

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cardiovascular Disease | Phase 1 | Status: COMPLETED